Axel Alonso
Axel Alonso is an American comic book editor and former Editor-in-Chief at Marvel Comics. He is known for his significant contributions to the comic book industry, particularly during his tenure at Marvel.
Early Life and Education[edit]
Axel Alonso was born on August 22, 1967, in San Francisco, California. He attended the University of California, Santa Cruz, where he earned a degree in sociology. He later pursued a master's degree in journalism at Columbia University.
Career[edit]
Early Career[edit]
Alonso began his career in the comic book industry at DC Comics, where he worked as a Vertigo editor. During his time at Vertigo, he edited several notable titles, including 100 Bullets, Hellblazer, and Preacher.
Marvel Comics[edit]
In 2000, Alonso joined Marvel Comics as a senior editor. He quickly made a name for himself by overseeing popular titles such as X-Men, Spider-Man, and The Incredible Hulk. Alonso was instrumental in launching the critically acclaimed X-Statix series and revitalizing the X-Men franchise.
In 2011, Alonso was promoted to Editor-in-Chief of Marvel Comics, succeeding Joe Quesada. During his tenure, he oversaw several major storylines and events, including Avengers vs. X-Men, Marvel NOW!, and Secret Wars. Alonso was known for his efforts to diversify Marvel's lineup, introducing new characters and promoting inclusive storytelling.
Post-Marvel Career[edit]
After leaving Marvel in 2017, Alonso co-founded AWA Studios (Artists, Writers & Artisans) with former Marvel executive Bill Jemas. AWA Studios aims to provide creators with more control over their work and has published several successful titles since its inception.
Legacy[edit]
Axel Alonso is widely regarded as a transformative figure in the comic book industry. His editorial vision and commitment to diversity have left a lasting impact on Marvel Comics and the broader comic book landscape.
Related Pages[edit]
Categories[edit]
Ad. Transform your life with W8MD's Budget GLP-1 injections from $75
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $75 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
